Piper Sandler上调施贵宝目标价至75美元
Bristol-Myers Squibb(US:BMY) Ge Long Hui·2026-02-24 08:25Piper Sandler将施贵宝的目标价从66美元上调至75美元，维持"增持"评级。(格隆汇) ...
Bristol-Myers Squibb(US:BMY) Ge Long Hui·2026-02-24 08:25Bristol-Myers Squibb(US:BMY) Ge Long Hui·2026-02-24 08:25